88IV - PR Newswire Asia's news - Health Care/Hospital


Bambusa Therapeutics Appoints Howard Liang, Ph.D. to its Board of Directors and Establishes Scientific Advisory Board Dr. Liang brings deep biopharma finance, strategy, and capital markets expertise to support the company's next phase of growth ... 2026-07-15T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
NYSE Content Update: Women's Health Equity Funding Up 41% in 2025 Report NYSE issues a pre-market daily advisory direct from the trading floor. ... 2026-07-15T Banking/Financial Service Computer/Electronics Health Care/Hospital
Ractigen Therapeutics Announces Landmark Publication in Nature Medicine Highlighting Unprecedented Preclinical Efficacy and Positive First-in-Human Clinical Data for RAG-17 in SOD1-ALS — Peer-reviewed publication details RAG-17's robust translation from "bench to bedside," validating the proprietary SCAD™ delivery platform for CNS-targeted RNAi therapies — ... 2026-07-15T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
POMDOCTOR LIMITED Advances Healthcare Data Asset Strategy to Strengthen AI-Powered Chronic Disease Management Capabilities GUANGZHOU, China , July 15, 2026 /PRNewswire/ -- POMDOCTOR LIMITED ("Pomdoctor" or the "Company") (NASDAQ: POM), a digital healthcare company focused on advancing AI-enabled ... 2026-07-15T Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Septa Pharmaceuticals Inc. Acquires CeeNU® (Lomustine) from Bristol Myers Squibb, Canada MISSISSAUGA, ON, July 15, 2026 /PRNewswire/ -- Septa Pharmaceuticals Inc. , a rapidly growing leader in the Canadian healthcare sector, is proud to announce the successful acquisition of CeeNU ® ... 2026-07-15T Health Care/Hospital Medical/Pharmaceuticals
Harbour BioMed and Kelun-Biotech Announce NMPA Approval of IND Application for HBM7575/SKB575 for the Treatment of Asthma CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI , July 15, 2026 /PRNewswire/ -- Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel ... 2026-07-15T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Ascletis Selects for Clinical Development a Fixed-Dose Combination of First-in-Class Oral Small Molecule GIPR Agonist, ASC48, and Oral Small Molecule GLP-1R Agonist, ASC30 - ASC48 is a potentially first-in-class oral small molecule GIPR agonist. ... 2026-07-15T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Kelun-Biotech and Harbour BioMed Announce NMPA Approval of IND Application for SKB575/HBM7575 for the Treatment of Asthma CHENGDU, China , July 15, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) and Harbour BioMed (HKEX: 02142) today ... 2026-07-15T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
NATIONAL UNIVERSITY HOSPITAL TO EXPAND WEARABLE TECHNOLOGY FOR PATIENT MONITORING FOLLOWING SUCCESSFUL PILOT Continuous smartwatch monitoring shown to safely support post-surgical care, reducing disruptions for patients and easing nursing time for direct patient care ... 2026-07-15T Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
LumaCina Appoints Gary Bird as CEO to Accelerate Growth and Expand Global Sterile Injectables Portfolio Executive Chair Mark Crotty to continue guiding long-term strategic direction ... 2026-07-15T Computer/Electronics Health Care/Hospital Medical/Pharmaceuticals

PR Newswire Asia's news > Health Care/Hospital